A New Approach to Alzheimer’s Disease
at the Institute for Systems Biology
News
A New Approach to Alzheimer’s Disease
The impact of Alzheimer’s Disease is staggering – 6 million Americans diagnosed, a financial toll of $600 billion annually, and no effective drug treatments. ISB Co-founder Dr. Lee Hood said the traditional approach isn’t working, and we need to think about it in brand new ways.
David Sinclair On Why We Age — And Why We Don’t Have To
Dr. David Sinclair, a Harvard Medical School professor and New York Times bestselling author, was the guest of honor for the ISB-Town Hall Science Series on Thursday. He joined genomics pioneer and ISB Co-founder Dr. Lee Hood for a conversation that covered the very latest in aging research.
Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More
NIAID Director Dr. Anthony Fauci sat down for a conversation with ISB’s Dr. Lee Hood. The renowned scientists spoke about the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19, lessons learned from the COVID-19 pandemic, and much more.
ISB Researchers Show Genetic Risk for Disease Often Reflected in Our Blood
Diseases develop gradually over years, sometimes decades, before symptoms appear, and are due to malfunctioning physiological processes brought about by our genes and environment. In research published in the journal Proceedings of the National Academy of Sciences (PNAS), ISB researchers have shown how an individual’s genetic risk for disease is often reflected in their blood.
ISB’s Dr. Nathan Price Inducted into AIMBE’s College of Fellows
Dr. Nathan Price has been inducted into the American Institute for Medical and Biological Engineering’s (AIMBE) College of Fellows. Price was nominated, reviewed, and elected by peers and members of the College of Fellows for his contributions deriving medical and biological insights from large-scale data analysis and network modeling, and translating those insights to society.
Expert Panel Discusses 21st Century Health at Town Hall Seattle Event
In a public panel discussion put on by Town Hall Seattle and ISB, legendary biologist Dr. Lee Hood, PSJH Chief Clinical Officer Dr. Amy Compton-Phillips, and PATH’s Program Leader of Diagnostics Tala de los Santos addressed the promise — and challenges — of implementing and practicing 21st century health care.
ISB’s Dr. Qiang Tian Joins Shanghai’s National Research Center for Translational Medicine
In the two decades since joining Dr. Lee Hood as a postdoc, Dr. Qiang Tian has made a tremendous impact on ISB’s science and culture. March 31 is his final day at ISB, as he is returning to China and joining Shanghai’s National Research Center for Translational Medicine.
Ozy’s ‘Future of X’ Podcast Features Drs. Jim Heath, Lee Hood
ISB President Dr. Jim Heath and ISB Co-founder Dr. Lee Hood are prominently featured in a new podcast created by Ozy, the popular news website. The podcast is called “The Future of X.” In the series’ first episode, Heath and Hood discuss cancer immunotherapy, personalized health care, and more.
‘Visions of the Future’ Symposium Honors Dr. Lee Hood on his 80th Birthday
An impressive lineup of renowned researchers gathered at ISB recently for a one-day symposium, titled “Visions of the Future,” to honor ISB co-founder Dr. Lee Hood on his 80th birthday. Presenters included Drs. Irv Weissman, Ralph Snyderman, Ellen Rothenberg, Roger Perlmutter, Jim Heath, Trey Ideker, and more.
New ‘scientific wellness’ strategy could cut chronic illnesses and save money
“Scientific wellness” should be widely adopted as a health strategy to avoid chronic illnesses and reduce health care costs, said ISB co-founder Dr. Lee Hood, speaking at the “Schrödinger at 75 conference” on the future of biology, in Dublin. Hood’s presentation was covered by The Irish Times.
The Decades-Long Path That Led Philanthropist Carole Ellison to ISB
Philanthropist Carole Ellison created the recently unveiled K. Carole Ellison Fellows in Bioinformatics. “It’s so exciting to be part of (young researchers’) lives and help them along in their careers,” Ellison said.
ISB’s proteomics research in the spotlight
Microsoft Research recently deployed a video crew to come to ISB to speak with our researchers about proteomics and sharing peptide data. A story featuring the video was published on the Microsoft Research blog.
Dr. Jim Heath Takes Helm of ISB, Looks Toward the Future
Jim Heath took over as president of Institute for Systems Biology on January 1. To fully appreciate Heath’s relationship with ISB, you have to go back to its early days – shortly after the research organization was founded in 2000.
Key Strategies for Implementing Proteomics-Based Tests Across Disease States Highlighted in Current Opinion in Biotechnology
ISB, Integrated Diagnostics and Sera Prognostics just announced a paper entitled, “The building blocks of successful translation of proteomics to the clinic,” by Leroy Hood and colleagues published online in Current Opinion in Biotechnology.
Clinical Trial Explores the Effects of Health Coaching on Cognitive Function in Patients with Early-Stage Alzheimer’s
Institute for Systems Biology (ISB) is among several organizations conducting a clinical trial testing how health coaching affects the cognitive function of patients with early-stage Alzheimer’s disease and analyzing longitudinal, multi-omic data to explore transitions in cognitive function over time.
Lessons I Learned from My 17 Years as ISB President
Lee Hood co-founded Institute for Systems Biology in 2000, and has served as president of the institution since; on January 1, 2018, he left that role to serve as chief science officer of Providence St. Joseph Health. Here, Hood shares the many lessons he learned from 17 years at the helm of ISB.
ISB Annual Report: Catalyzing A Revolution
ISB’s compass has always been oriented toward the future. Even when we reflect on the past year for each annual report, it’s always through the lens of what’s on the horizon. We are remarkably consistent in that regard, which is in no small part due to our president Dr. Lee Hood, whose vision is perpetually a decade – at least – ahead of everyone else. In this year’s letter, Dr….
Our Artwork Featured On Cover of Nature Biotechnology
The Institute for Systems Biology and Arivale “Pioneer 100 Study” is featured on the cover of August’s Nature Biotechnology. The artwork was created by ISB’s Associate Director of Communications Allison Kudla in collaboration with contributing author John C. Earls, software engineer in the Hood-Price Lab. About the cover: A subset of statistically significant correlations are extruded in three-dimensional space. Price et al. describe the integration of whole genome sequences; clinical…